Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
47,622,569
-
Share change
-
+47,621,269
-
Total reported value
-
$349,319,767
-
Put/Call ratio
-
0.25%
-
Price per share
-
$7.35
-
Number of holders
-
82
-
Value change
-
+$349,310,767
-
Number of buys
-
81
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2017
As of 30 Jun 2017 IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) had 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,622,569 shares of stock of the company.
Largest 10 holders included BlackRock Inc., FRANKLIN RESOURCES INC, PERCEPTIVE ADVISORS LLC, venBio Select Advisor LLC, ACUTA CAPITAL PARTNERS, LLC, ORBIMED ADVISORS LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, Broadfin Capital, LLC, and VANGUARD GROUP INC.
This table shows 82 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.